Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy

Published:2008-12-04 Issue:1 Volume:89 Page:76-79
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Colagrande Marianna,Di Ianni Mauro,Coletti Gino,Peris Ketty,Fargnoli Maria Concetta,Moretti Lorenzo,Lapecorella Mario,Tabilio Antonio

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-008-0220-2.pdf

Reference21 articles.

1. Hoffman R, Rondelli D. Biology and treatment of primary myelofibrosis. Hematology (Am Soc Hematol Educ Program). 2007;2007:346–54. doi: 10.1182/asheducation-2007.1.346 .

2. Mirza I, Sekora D, Frantz C. Testing for JAK2 V617F mutation across specimen types yields concordant results. J Clin Pathol. 2008;61:975. doi: 10.1136/jcp.2007.054379 .

3. Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, et al. Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone. Leukemia. 2007;21:377–8. doi: 10.1038/sj.leu.2404505 .

4. Odenike O, Tefferi A. Conventional and new treatment options for myelofibrosis with myeloid metaplasia. Semin Oncol. 2005;32:422–31. doi: 10.1053/j.seminoncol.2005.06.014 .

5. Kerbauy DM, Gooley TA, Sale GE, Flowers ME, Doney KC, Georges GE, et al. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biol Blood Marrow Transplant. 2007;13:355–65. doi: 10.1016/j.bbmt.2006.11.004 .

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review;The Journal of Laryngology & Otology;2018-09-07

2. Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies;Journal of Immunology Research;2018

3. Current perspective on the role of TNFα inhibitors in treating patients with toxic epidermal necrolysis;Klinická farmakologie a farmacie;2016-12-01

4. Life-threatening dermatologic adverse events in oncology;Anti-Cancer Drugs;2014-02

5. Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database;Medical Oncology;2013-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3